WHO: Preparations containing predominantly CBD and not more than 0,2 % of THC are not under international control but….

TRADELABOR has more than 20 years of experience in the control and treatment of air, working with an experienced and qualified technical staff and with the most advanced technology in this area, which together guarantee the quality of the services provided.



According to the assessment of the WHO Expert Committee, cannabidiol is found in
cannabis and cannabis resin but does not have psychoactive properties and has no
potential for abuse and no potential to produce dependence. It does not have
significant ill-effects. Moreover, cannabidiol has been shown to be effective in the
management of certain treatment-resistant, childhood-onset epilepsy disorders.

The WHO noted that medicines without psychoactive effects that are produced as
preparations of the cannabis plant will contain trace amounts of delta-9-
tetrahydrocannabinol and acknowledged that chemical analysis of delta-9-
tetrahydrocannabinol to an accuracy of 0.15 % may be difficult for some Member
States. Thus, the WHO recommended that a footnote be added to Schedule I of the
Convention on Narcotic Drugs to read: “Preparations containing predominantly
cannabidiol and not more than 0,2 % of delta-9-tetrahydrocannabinol are not under
international control.”

However, that recommendation would lower current control level for these
preparations, the establishment of any THC limit for preparations containing
predominantly cannabidiol is not supported by scientific evidence, and the wording of
the recommendation does not exclude possible divergent interpretations concerning
the way of calculating such limit. The differentiated treatment of cannabidiol
compared to other cannabinoids is not justified and is not in line with the existing
structure of the Schedules of the Conventions.

Therefore, the Member States should take the position that the recommendation should
not be put to vote and further assessment by WHO should be requested.

Continue at: https://ec.europa.eu/transparency/regdoc/rep/1/2019/EN/COM-2019-624-F1-EN-MAIN-PART-1.PDF

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:



Manostaxx – Industrial Management Consulting

Leave a Reply

Your email address will not be published. Required fields are marked *